百洋医药：百洋医药集团有限公司累计质押股数约为1.64亿股

Group 1 - Baiyang Pharmaceutical has pledged approximately 164 million shares, accounting for 46.33% of its total holdings [1] - Beijing Baiyang Chengchuang Pharmaceutical Investment Co., Ltd. has pledged 9.98 million shares, representing 49.9% of its holdings [1] - Tianjin Huitong Asset Management Partnership has pledged 2.8 million shares, which is 48.86% of its holdings [1] Group 2 - Baiyang Pharmaceutical's revenue composition for 2024 is as follows: 92.5% from sales of pharmaceuticals and medical devices, 7.18% from brand services, and 0.32% from other businesses [1] - As of the report date, Baiyang Pharmaceutical's market capitalization is 12.7 billion yuan [1]